Influence of genetic variants on toxicity to anti-tubercular agents: a systematic review and meta-analysis (protocol)

Abstract Background Tuberculosis patients receiving anti-tuberculosis treatment may experience serious adverse drug reactions, such as hepatotoxicity. Genetic risk factors, such as polymorphisms of the NAT2, CYP2E1 and GSTM1 genes, may increase the risk of experiencing such toxicity events. Many pha...

Full description

Bibliographic Details
Main Authors: Marty Richardson, Jamie Kirkham, Kerry Dwan, Derek Sloan, Geraint Davies, Andrea Jorgensen
Format: Article
Language:English
Published: BMC 2017-07-01
Series:Systematic Reviews
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13643-017-0533-4